E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Cancer metastasis follows a sequential series of events, and many of the critical steps are distinctly similar to EMT-like transformations that occur during normal embryonic development. A current area of focus is the similarities between how cancer cells interact with the ectopic parenchyma after metastatic spread, and secondary developmental MET events that occur in epithelial tissues that have re-assembled within the embryo from mesenchymal cells. Accumulating evidence suggests a critical role for these secondary events, termed mesenchymal-epithelial transitions (MET) in development and mesenchymal-epithelial reverting transitions (MErT) in cancer. In this situation, metastatic seed cancer cells may inertly become part of the ectopic tissue and therefore surmount the metastatic inefficiencies to which most disseminated cancer cells succumb. Just as a critical EMT event is the downregulation or silencing of E-cadherin, we discuss the role of E-cadherin in cancer-associated MErT at distant metastatic sites and speculate on the implications for the fate of micrometastases that undergo a transition to being E-cadherin positive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 2×
“Many years ago it was appreciated that tumor cells disseminate preferentially to ectopic tissues based mainly on the ability of that host tissue to support the survival and proliferation of those cells [9].”
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
Nelson, W. J., & Nusse, R. (2004) · Science · doi:10.1126/science.1094291 · Cited by 2,515
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
Regulation of cadherin-mediated adhesion in morphogenesis
Gumbiner, B. M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1699 · Cited by 1,523
Multistep Nature of Metastatic Inefficiency
Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., & Groom, A. C. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65628-3 · Cited by 1,243
Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression
Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., & Thompson, E. W. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21223 · Cited by 1,091
Christiansen, J. J., & Rajasekaran, A. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0410 · Cited by 1,046
New signals from the invasive front
Christofori, G. (2006) · Nature · doi:10.1038/nature04872 · Cited by 993
Jones, R. (2002) · Nature Reviews Genetics · doi:10.1038/nrg962 · Cited by 828
Moustakas, A., & Heldin, C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00550.x · Cited by 804
The role of epithelial-mesenchymal transition in cancer pathology
guarino, M., rubino, B., & ballabio, G. (2007) · Pathology · doi:10.1080/00313020701329914 · Cited by 790
Carcinoma Invasion and Metastasis: A Role for Epithelial-Mesenchymal Transition?
Thompson, E. W., & Newgreen, D. F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0616 · Cited by 667
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases
Shah, R. B., Mehra, R., Chinnaiyan, A. M., Shen, R., Ghosh, D., Zhou, M., MacVicar, G. R., Varambally, S., Harwood, J., Bismar, T. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2442 · Cited by 617
Invasive growth: a MET-driven genetic programme for cancer and stem cells
Boccaccio, C., & Comoglio, P. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1912 · Cited by 538
The Fallacy of Epithelial Mesenchymal Transition in Neoplasia
Tarin, D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0699 · Cited by 531
Reynolds, A. B., Daniel, J., McCrea, P. D., Wheelock, M. J., Wu, J., & Zhang, Z. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8333 · Cited by 480
Autoregulation of E-cadherin expression by cadherin–cadherin interactions
Conacci-Sorrell, M., Simcha, I., Ben-Yedidia, T., Blechman, J., Savagner, P., & Ben-Ze'ev, A. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200308162 · Cited by 474
E-cadherin expression in primary carcinomas of the breast and its distant metastases
Kowalski, P. J., Rubin, M. A., & Kleer, C. G. (2003) · Breast Cancer Research · doi:10.1186/bcr651 · Cited by 414
Graff, J. R., Gabrielson, E., Fujii, H., Baylin, S. B., & Herman, J. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2727 · Cited by 393
Tumor Invasion: Role of Growth Factor-Induced Cell Motility
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)61023-4 · Cited by 330
Hazan, R. B., & Norton, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9078 · Cited by 253
Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment
Kopfstein, L., & Christofori, G. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5296-8 · Cited by 229
Stessels, F., Van den Eynden, G., Van der Auwera, I., Salgado, R., Van den Heuvel, E., Harris, A. L., Jackson, D. G., Colpaert, C. G., Van Marck, E. A., Dirix, L. Y., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601727 · Cited by 214
Jones, R. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn993 · Cited by 209
Epigenetic versus genetic alterations in the inactivation of E-cadherin
Strathdee, G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00057-3 · Cited by 192
Kang, H.-G., Jenabi, J. M., Zhang, J., Keshelava, N., Shimada, H., May, W. A., Ng, T., Reynolds, C. P., Triche, T. J., & Sorensen, P. H. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3259 · Cited by 184
Gleave, M. E., Hsieh, J. T., Von Eschenbach, A. C., & Chung, L. W. K. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37506-7 · Cited by 179
Suppression of tumorigenicity by plakoglobin: an augmenting effect of N-cadherin.
Simcha, I., Geiger, B., Levenberg, S., Salomon, D., & Ben‐Ze'ev, A. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.133.1.199 · Cited by 152
Yates, C. C., Shepard, C. R., Stolz, D. B., & Wells, A. H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603700 · Cited by 148
Self-citationReddy, P., Liu, L., Ren, C., Lindgren, P., Boman, K., Shen, Y., Lundin, E., Ottander, U., Rytinki, M., & Liu, K. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0342 · Cited by 137
EGF receptor signaling in prostate morphogenesis and tumorigenesis.
Kim, H. G., Kassis, J. N., Souto, J. C. S., Turner, T., & Wells, A. H. (1999) · PubMed · doi:10.14670/hh-14.1175 · Cited by 100
Self-citationYates, C. C., Shepard, C. R., Papworth, G. D., Dash, A., Stolz, D. B., Tannenbaum, S. R., Griffith, L. G., & Wells, A. H. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)97010-9 · Cited by 87
Self-citationKaihara, T., Kawamata, H., Imura, J., Fujii, S., Kitajima, K., Omotehara, F., Maeda, N., Nakamura, T., & Fujimori, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01414.x · Cited by 61
Mamoune, A., Kassis, J. N., Kharait, S., Kloeker, S., Manos, E., Jones, D. A., & Wells, A. H. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.05.008 · Cited by 58
Self-citationYates, C. C., Wells, A. H., & Turner, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602350 · Cited by 51
Self-citation
Cited by
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
Ribatti, D., Tamma, R., & Annese, T. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100773 · Cited by 1,001
TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
Principe, D. R., Doll, J. A., Bauer, J., Jung, B., Munshi, H. G., Bartholin, L., Pasche, B., Lee, C., & Grippo, P. J. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt369 · Cited by 523
Yao, D., Dai, C., & Peng, S. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0568 · Cited by 455
Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
Chao, Y. L., Shepard, C. R., & Wells, A. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-179 · Cited by 411
Self-citationThe role of exosomes in cancer metastasis
Steinbichler, T. B., Dudás, J., Riechelmann, H., & Skvortsova, I.-I. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.02.006 · Cited by 389
Metadata
- Authors
- Wells, A., Yates, C., & Shepard, C. R.
- Venue
- Clinical & Experimental Metastasis
- Published
- 2008-07-04
- Volume
- 25
- Issue
- 6
- Pages
- 621-628
- ISSN
- 0262-0898 (ISSN-L)
- 1573-7276
- OpenAlex
- W1976736011
- Cited by
- 353
- References
- 41
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.